Laivins; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Laivins; Peter.The latest application filed is for "methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan".

Company Profile

6.8.14

Laivins; Peter - Rowayton CT
Laivins; Peter - Scituate MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating pancreatic cancer using combination therapies Grant 11,369,597 - Bayever , et al. June 28, 2	2022-06-28
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20220096458 - Bayever; Eliel ; et al.	2022-03-31
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 10,980,795 - Bayever , et al. April 20, 2	2021-04-20
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 10,744,130 - Bayever , et al. A	2020-08-18
Methods For Treating Pancreatic Cancer Using Combination Therapies App 20190117644 - Bayever; Eliel ; et al.	2019-04-25
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20190117643 - Bayever; Eliel ; et al.	2019-04-25
Methods for Treating Pancreatic Cancer Using Combination Therapies App 20180008591 - Bayever; Eliel ; et al.	2018-01-11
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20170368056 - Bayever; Eliel ; et al.	2017-12-28
Methods for treating pancreatic cancer using combination therapies Grant 9,717,724 - Bayever , et al. August 1, 2	2017-08-01
Treatment Of Pancreatic Cancer With Liposomal Irinotecan App 20170202840 - Bayever; Eliel ; et al.	2017-07-20
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20170065578 - Bayever; Eliel ; et al.	2017-03-09
Methods For Treating Pancreatic Cancer Using Combination Therapies App 20170049768 - Bayever; Eliel ; et al.	2017-02-23
Methods for Treating Pancreatic Cancer Using Combination Therapies App 20160375004 - BAYEVER; ELIEL ; et al.	2016-12-29
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 9,492,442 - Bayever , et al. November 15, 2	2016-11-15
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 9,452,162 - Bayever , et al. September 27, 2	2016-09-27
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20160228428 - Bayever; Eliel ; et al.	2016-08-11
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 9,364,473 - Bayever , et al. June 14, 2	2016-06-14
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan Grant 9,339,497 - Bayever , et al. May 17, 2	2016-05-17
Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20160074382 - BAYEVER; ELIEL ; et al.	2016-03-17
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20150374682 - BAYEVER; ELIEL ; et al.	2015-12-31
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20150328156 - BAYEVER; ELIEL ; et al.	2015-11-19
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan App 20150182521 - Bayever; Eliel ; et al.	2015-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.